Studying autoimmunity by in vivo RNA interference Publication: Journal Article Kissler, Stephan. 2009. “Studying Autoimmunity by in Vivo RNA Interference”. Methods Mol Biol 555: 109-18.
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Publication: Journal Article Thum, Thomas, Carina Gross, Jan Fiedler, Thomas Fischer, Stephan Kissler, Markus Bussen, Paolo Galuppo, et al. 2008. “MicroRNA-21 Contributes to Myocardial Disease by Stimulating MAP Kinase Signalling in Fibroblasts”. Nature 456 (7224): 980-4.
Collective Cancer Invasion Forms an Integrin-Dependent Radioresistant Niche Publication: Journal Article A, Haeger, Alexander S, . , Kissler S, and Friedl P. 2020. “Collective Cancer Invasion Forms an Integrin-Dependent Radioresistant Niche”. J Exp Med 217 (1).
Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes Publication: Journal Article Cai, EP, Ishikawa, Zhang, NC Leite, Li, Hou, Kiaf, et al. 2020. “Genome-Scale in Vivo CRISPR Screen Identifies RNLS As a Target for Beta Cell Protection in Type 1 Diabetes”. Nature Metabolism 2 (9): 934-45.
The autoimmunity-associated gene RGS1 affects the frequency of T follicular helper cells Publication: Journal Article Caballero-Franco, Celia, and Stephan Kissler. 2016. “The Autoimmunity-Associated Gene RGS1 Affects the Frequency of T Follicular Helper Cells”. Genes Immun 17 (4): 228-38.
PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant Publication: Journal Article Zheng, Peilin, and Stephan Kissler. 2013. “PTPN22 Silencing in the NOD Model Indicates the Type 1 Diabetes-Associated Allele Is Not a Loss-of-Function Variant”. Diabetes 62 (3): 896-904.
The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function Publication: Journal Article Gerold, Kay, Peilin Zheng, Daniel Rainbow, Alma Zernecke, Linda Wicker, and Stephan Kissler. 2011. “The Soluble CTLA-4 Splice Variant Protects from Type 1 Diabetes and Potentiates Regulatory T-Cell Function”. Diabetes 60 (7): 1955-63.
Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes Publication: Journal Article Dillon, Christopher, Peter Sandy, Alessio Nencioni, Stephan Kissler, Douglas Rubinson, and Luk Van Parijs. 2005. “Rnai As an Experimental and Therapeutic Tool to Study and Regulate Physiological and Disease Processes”. Annu Rev Physiol 67: 147-73.
RNA interference for the identification of disease-associated genes Publication: Journal Article Nencioni, Alessio, Peter Sandy, Christopher Dillon, Stephan Kissler, Peter Blume-Jensen, and Luk Van Parijs. 2004. “RNA Interference for the Identification of Disease-Associated Genes”. Curr Opin Mol Ther 6 (2): 136-40.
Cross-reactivity and T-cell receptor antagonism of myelin basic protein-reactive T cells is modulated by the activation state of the antigen presenting cell Publication: Journal Article Kissler, Stephan, Stephen Anderton, and David Wraith. 2002. “Cross-Reactivity and T-Cell Receptor Antagonism of Myelin Basic Protein-Reactive T Cells Is Modulated by the Activation State of the Antigen Presenting Cell”. J Autoimmun 19 (4): 183-93.